New Targeted Radiopharmaceuticals and Techniques for Nuclear Imaging of Inflammation

Dear Colleagues,

Inflammation is involved in disease progressing and healing, thus having a significant role in diagnosis and therapy. Upon inflammation, a number of biomarkers are upregulated, which provides opportunities for early diagnosis with, for example, nuclear medicine approaches. To read out the biomarker profile in an inflammatory disease, different types of radiolabeled probes and imaging techniques are continuously needed. The aim of this Special Issue in Biomolecules is to promote the dissemination of fresh research results on inflammation imaging. More specifically, this Special Issue is dedicated to radiopharmaceuticals and imaging techniques for inflammatory diseases with positron emission tomography and single-photon emission computed tomography, in the context of preclinical and clinical evaluation of new radiopharmaceuticals. Studies can be from basic research in new radiopharmaceutical development, as well as new imaging methods and applications with existing radiopharmaceuticals in preclinical and clinical settings. It is equally valuable to receive reports on clinical cases with extraordinarily good imaging performances, even though neither the imaging probes nor the techniques are new.

Prof. Dr. Anne Roivainen
Dr. Xiang-Guo Li
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.